Clinical trial
Percutaneous Intramyocardial Cell Therapy After Acute Myocardial Infarction Using Bone Marrow Mononuclear Cells
NCT00939042 is registered in ClinicalTrials.gov with Asklepios proresearch as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Percutaneous Intramyocardial Cell Therapy After Acute Myocardial Infarction Using Bone Marrow Mononuclear Cells
- Lead sponsor
- Asklepios proresearch
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 31, 2009
- Completion date
- January 31, 2014
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myocardial infarction, early left ventricular dysfunction